Acute macular neuroretinopathy following Moderna COVID-19 vaccination
Abstract Purpose To describe the occurrence of an acute macular neuroretinopathy (AMN) after administration of a Moderna COVID-19 Vaccine. Methods Case report. Results A 23-year-old female presented bilateral visual loss one week after the first dose of COVID-19 vaccine. Fundus examination revealed...
Main Authors: | Olena Protsyk, Roberto Gallego-Pinazo, Rosa Dolz-Marco |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-06-01
|
Series: | Journal of Ophthalmic Inflammation and Infection |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12348-023-00354-1 |
Similar Items
-
Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination
by: Daniel A. Valenzuela, et al.
Published: (2021-12-01) -
Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination
by: Shunsuke Ikema, et al.
Published: (2023-11-01) -
Bilateral paracentral acute middle maculopathy and acute macular neuroretinopathy following COVID-19 vaccination
by: Sirisha Vinzamuri, et al.
Published: (2021-01-01) -
Acute macular neuroretinopathy in dengue virus serotype 1
by: Gabriel A. Guardiola, et al.
Published: (2022-03-01) -
COVID-19 Related Acute Macular Neuroretinopathy (AMN): A Case Series
by: Vu TA, et al.
Published: (2023-08-01)